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Integrative Physiology/Experimental Medicine
Role of Delta-like-4/Notch in the Formation and Wiring of
the Lymphatic Network in Zebrafish
Ilse Geudens, Robert Herpers, Karlien Hermans, Inmaculada Segura, Carmen Ruiz de Almodovar,
Jeroen Bussmann, Frederik De Smet, Wouter Vandevelde, Benjamin M. Hogan, Arndt Siekmann,
Filip Claes, John C. Moore, Anna Silvia Pistocchi, Sonja Loges, Massimiliano Mazzone,
Giovanni Mariggi, Franc¸oise Bruye`re, Franco Cotelli, Dontscho Kerjaschki, Agnes Noe¨l,
Jean-Michel Foidart, Holger Gerhardt, Annelii Ny, Tobias Langenberg, Nathan D. Lawson,
Henricus J. Duckers, Stefan Schulte-Merker, Peter Carmeliet, Mieke Dewerchin
Objective—To study whether Notch signaling, which regulates cell fate decisions and vessel morphogenesis, controls
lymphatic development.
Methods and Results—In zebrafish embryos, sprouts from the axial vein have lymphangiogenic potential because they
give rise to the first lymphatics. Knockdown of delta-like-4 (Dll4) or its receptors Notch-1b or Notch-6 in zebrafish
impaired lymphangiogenesis. Dll4/Notch silencing reduced the number of sprouts producing the string of parchordal
lymphangioblasts; instead, sprouts connecting to the intersomitic vessels were formed. At a later phase, Notch silencing
impaired navigation of lymphatic intersomitic vessels along their arterial templates.
Conclusion—These studies imply critical roles for Notch signaling in the formation and wiring of the lymphatic network.
(Arterioscler Thromb Vasc Biol. 2010;30:1695-1702.)
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The lymphatic vasculature regulates interstitial fluid ho-meostasis, fat resorption, immune defense, inflammation,
and metastasis.1 In mammals, venous blood vascular endothelial
cells (BECs) differentiate to lymphatic endothelial cells (LECs).1
In response to Sox18, prospero homeobox-1 (Prox-1) induces
the lymphatic transdifferentiation of venous BECs.1,2 Additional
cues must regulate lymphatic development; however, their
nature remains unknown. Another outstanding question is how
lymphatics become wired into a stereotyped network. Deep
lymphatics regularly fasciculate with other vessels and track
along arteries.1,3 Similar to blood vessels,4 lymphatic sprouts
have tip cells with filopodia to probe guidance cues.5 Although
molecules such as vascular endothelial growth factor receptor
(VEGFR)-3, VEGF-C, Neuropilin-2, and Ccbe1 regulate lym-
phatic migration,1,6 the navigation of lymphatics remains poorly
understood. Thus, the mechanisms and molecules underlying
lymphatic development and wiring remain largely unknown.
See accompanying article on page 1682
Intriguingly, despite the venous origin of lymph vessels,
several molecules involved in arterial BEC regulation also
regulate lymphangiogenesis. For instance, EphrinB2, an
initial marker of arterial BECs,7,8 regulates lymphatics
later in development.1 Sox18, together with Sox7, is
required for arterial differentiation and later regulates
lymphatic competence.2 This relationship between “arteri-
al” factors and lymphangiogenesis, and the anatomical
congruence between arteries and lymphatics,8 –11 prompted
us to investigate whether Notch also regulates lymphatic
development. Notch and its ligand delta-like-4 (Dll4)
seemed intriguing candidates, given their role in vessel
branching.4 By using gene silencing methods in zebrafish,
we revealed novel roles for Dll4/Notch signaling at mul-
tiple steps during early lymphangiogenesis.
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Methods
Zebrafish Husbandry
The transgenic zebrafish lines used were Fli1:eGFPy1,12 Flt1:YFP,
kdr-l:mCherryRed, Stab1:YFP, Fli1:DsRed,6 Tp1bglob:eGFP,13 and
intercrosses. Embryos and fish were grown and maintained as
previously described.6,14 All animal experimentation was approved
by the institutional ethical committee.
Morpholino Injection
Morpholinos (Gene Tools, LLC, Corvallis, Ore) (supplemental
Table I; all supplemental materials are available online at
http://atvb.ahajournals.org) were injected at the indicated doses, as
previously described.14 Phenotyping data are pooled data from at
least 3 independent experiments, with analysis of 33 to 185 injected
embryos per dose. Screening methods for the evaluation of lym-
phatic development and functionality are detailed in the supplemen-
tal Methods.
RNA Analysis and Cell Culture Assays
Whole-mount in situ hybridization of dechorionated embryos using
antisense probes for the indicated genes (supplemental Methods) was
performed as previously described.14 Quantitative RT-PCR was
performed on whole embryo extracts or on fluorescence-activated
cell sorted embryo cells after in vivo labeling of LECs, as described
in the supplemental Methods. The proliferation, migration, and
expression analyses of LECs or human umbilical venous ECs are
detailed in the supplemental Methods.
Statistical Analysis
Each gene-specific morpholino was always compared with a
control morpholino or vehicle. To determine the penetrance of the
phenotype, we counted the number of embryos exhibiting different
phenotype severities, and analyzed distributions by 2. Unpaired
comparisons were performed by a 2-sided t test. Asterisks represent
a significance level of P0.05.
Results
Knockdown of Dll4 and Notch-1b or Notch-6
Impairs Thoracic Duct Formation
To explore a role for Notch signaling in lymphatic development
(supplemental Note I and supplemental Figure I), we silenced
every known zebrafish orthologue of the Notch ligands
(DeltaA-D, Dll4, Jagged-1a/b, and Jagged-2) and receptors
(Notch-1a/b, Notch-5, and Notch-6) and the Notch-activating
presenilins-1/2 in Fli1:eGFPy1 zebrafish embryos, in which
lymphatic, arterial, and venous ECs are labeled.12,15,16 Submaxi-
mal silencing conditions were used (supplemental Note II); these
conditions did not affect general or blood vascular development
(supplemental Figure II and supplemental Figure III). Develop-
ment of the thoracic duct (TD), the first functional lymphatic
formed in the trunk in between the dorsal aorta (DA) and the
posterior cardinal vein (PCV), was analyzed (supplemental Note
III defines acronyms).
Dll4 morpholino knockdown (Dll4KD) inhibited TD forma-
tion. On injection of a morpholino affecting Dll4 mRNA
splicing (Dll4SPL, 10 ng), the TD failed to form at all by 6
days post fertilization (dpf) in 52% of morphant embryos,
indicating that lymphatic development was completely
aborted (Figure 1A, B, and D). In another 27% of Dll4SPL
embryos, the TD formed over only 10% to 30% of its normal
length, whereas in another 15% of morphant embryos, the TD
formed over 30% to 90% of its normal length (Figure 1D).
Follow-up studies at 12 dpf revealed that, in embryos with
intermediate defects, the TD segments that did form failed to
reconstitute the entire TD and to compensate for the lym-
phatic failure in nearby somites (not shown). Dll4KD embryos
without TD at 6 dpf also failed to form a TD, even partially,
at later stages (supplemental Figure IIG and H), indicating
Figure 1. Role of Notch in TD formation.
A through C, Confocal images of GFP
vessels in Fli1:eGFPy1 embryos. Normal
TD in control (yellow arrowheads; A) and
absent TD in Dll4KD (B) and Notch-1bKD
(C) embryos. Yellow asterisks indicate
TD absence; red arrowheads, minimal
hyperbranching of ISVs. D through F,
Percentage of affected embryos in con-
trol (n122 in D, n185 in E, and n87
in F) or Dll4KD embryos (n80; 10-ng
Dll4SPL; P0.001; D); Notch-1bKD
(N1bKD) embryos (n84; 15-ng Notch-
1bSPL; P0.001; E), Notch-6KD (N6KD)
embryos (n63; 15-ng Notch-6SPL;
P0.001; E), PS-1KD embryos (n65;
2.5-ng PS-1ATG1; P0.001; F), or
embryos treated with DMSO (n171; F)
or DAPT (n34; 25-mol/L; P0.001; F).
G and H, Lymphangiography in 7-dpf
kdr-l:mCherryRed embryos revealed nor-
mal uptake and drainage of a green dye
by the TD in the control embryo (yellow
arrowheads; G), but not in the Dll4KD
embryo (yellow asterisks; H). The bar
indicates 50 m.
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that lymphatic development was not simply delayed but
aborted. Similarly, incomplete silencing of Notch-1b and, to
a lesser extent, Notch-6 impaired TD formation (Figure 1C
and E). Of note, their mammalian orthologues, Notch-1 and
Notch-2, are expressed in LECs.10,17 Because Notch-1b
downregulation causes more penetrant lymphatic defects,
only data for Notch-1bKD are shown.
Similar TD defects were obtained with morpholinos, targeting
the ATG of Dll4 (Dll4ATG) or Notch-1b (Notch-1bATG) (data not
shown); however, silencing of the Notch ligands DeltaA-D,
Jagged-1a/b, Jagged-2, or receptors Notch-1a, or Notch-5 (or-
thologue of mammalian Notch-3) did not induce lymphatic
defects (data not shown). Finally, inhibition of the -secretase
complex (which proteolytically activates Notch)18 confirmed the
involvement of Notch in lymphatic development. Both morpho-
lino knockdown of presenilin-1 (PS-1) (but not PS-2) and
pharmacological inhibition of -secretase activity by N-[N-(3,5-
difluorophenacetyl)-L-alanyl]-Sphenylglycine t-butyl ester
(DAPT)18 impaired TD formation (Figure 1F, supplemental
Figure IVQ and R, and supplemental Note II).
Lymphangiography in 7-dpf kdr-l:mCherryRed Dll4KD em-
bryos (in which only blood vessels express mCherryRed) re-
vealed no drainage of fluorescent dye in the region in which the
TD normally forms, confirming that the lack of a GFP TD in
Fli1:eGFPy1 Dll4KD embryos was not the result of reduced
expression of GFP, but the actual absence of the vessel itself
(Figure 1G and H). This assay further showed that partial TD
fragments were not functional (data not shown).
Notch Is Required for Parachordal
Lymphangioblast String Formation
Next, we analyzed whether silencing of Notch impaired
development of the parachordal lymphangioblast (PL) cells6
at the horizontal myoseptum because these precursors con-
tribute to TD formation (supplemental Note I and supplemen-
tal Figure I). At 52 hours post fertilization (hpf), the forma-
tion of the PL string was completely formed in 53% and
largely completed in 40% of embryos (Figure 2A). In
contrast, in Dll4SPL embryos, the PL string was completely
absent in 38% and formed only in a few segments in 27% of
embryos (Figure 2A). Largely comparable fractions of
Dll4SPL embryos exhibited similar types of PL string and TD
defects (compare Figure 1D with Figure 2A), suggesting that
the TD defects were, at least in part, attributable to defects in
PL string formation. Imaging of lymphangiogenic structures
in Dll4SPL embryos using the Stab1:YFP line,6 which primar-
ily visualizes venous and LECs, confirmed these findings
(Figure 2B and C). A similar absence of the PL string was
Figure 2. Silencing of Notch blocks PL and lymphangiogenic sprout formation. A, Percentage of 52-hpf embryos with affected PL in
control (n73), Dll4KD embryos (n55; 10-ng Dll4SPL; P0.001), or Notch-1bKD embryos (N1bKD) (n49; 20-ng Notch-1bATG; P0.001).
B and C, Confocal images of 52-hpf Stab1:YFP embryos, showing normal PL in controls (arrowheads; B), but absence in Dll4KD
embryos (asterisks; C). D and E, Whole-mount in situ Tie2 staining at 50 hpf, revealing normal numbers of secondary sprouts (arrow-
heads) in control (D) and Dll4KD (E) embryos. F and G, Confocal images of vessels in Flt1:YFPxkdr-l:mCherryRed embryos: kdr-
l:mCherryRed marks venous and arterial vessels red (red channel not shown), Flt1:YFP labels arterial vessels green (F and G), and
merged images show arterial vessels yellow and venous vessels red (F’and G’). Lateral views with left and right side ISVs partially
superimposed. Imaging was at 54 hpf, when secondary angiogenic sprouts had already connected to primary ISVs, which were chang-
ing arterial to venous identity in a ventral-to-dorsal pattern. In controls (F and F’), half of the aISVs became connected by angiogenic
sprouts from the PCV and acquired a venous identity, thereby losing their green arterial signal (blue arrows; F) and becoming red only
(blue arrows; F’), whereas the other half of the ISVs remained connected to the DA and were green (white arrows; F) or yellow in the
merged image (white arrows; F’). In contrast, in the Dll4KD embryo (G and G’), most ISVs lost their green arterial marker (blue arrows;
G; note the single white arrow), and became marked in red only (blue arrows in G’). The white arrow in G and G’ denotes a residual
aISV retaining its green (G) or yellow (G’) label. The bar indicates 50 m (B, C, F, and G) or 100 m (D and E).
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observed when using the Dll4ATG morpholino (data not
shown) or on knockdown of Notch-1b (Figure 2A) or
Notch-6 (data not shown). Because the string of PL cells
forms as a result of sprouting from the PCV (supplemental
Note I and supplemental Figure I),6 these findings suggest that
Notch signaling acts in part at early steps.
Dll4 Silencing Reduces the Fraction of
Lymphangiogenic Sprouts
Then, we studied whether inhibition of Notch acts during
branching of PL-forming secondary sprouts from the PCV
(termed “lymphangiogenic” secondary sprouts, denoting that
they participate in the process that leads to the formation of
lymphatic structures, but not blood vessels) (supplemental
Note I). Whole-mount staining for Tie2, which marks all
secondary sprouts,19 showed a normal total number in Dll4KD
embryos (N20) (Figure 2D and E). However, high-
resolution imaging of 4-dpf Fli1:eGFPy1 embryos revealed
alterations in the proportion of venous intersomitic vessels
(vISVs) connected to the PCV. In control embryos, half of the
ISVs were vISVs (percentage of total ISVs: 541%;
meanSEM; N49); in contrast, in Dll4SPL embryos,
821% of the ISVs were connected to the PCV and, thus,
vISVs (meanSEM; N97; P0.05 versus control). Similar
findings were obtained in Notch-1bSPL embryos (vISVs, portion
of total: 69.02.7%; meanSEM; N27; P0.05 versus con-
trol). Because vISVs can only be formed via connection of a
secondary “angiogenic” sprout to a primary ISV (supplemental
Note I), these findings, and the observation that silencing of
Dll4, Notch-1b, or Notch-6 aborted PL string formation in a
substantial fraction of embryos, show that a fraction of second-
ary sprouts that would normally have been lymphangiogenic
were angiogenic, thereby impairing TD formation.
We also used high-resolution video-imaging of the double
transgenic reporter line Flt1:YFPxkdr-l:mCherryRed,6 label-
ing venous cells red (CherryRed) and arterial cells yellow
(YFPCherryRed) in merged images.6 In control embryos,
half of the ISVs had a red venous color and the other half had
a yellow arterial color (Figure 2F and F). In contrast, in
Dll4KD embryos with severe lymphatic defects, nearly all
yellow arterial ISV (aISV) connections with the DA had
disappeared (single white arrow in Figure 2G and G)
(supplemental Movies I and II). Thus, a supernumerary
fraction of vISV-producing angiogenic sprouts is formed in
Dll4KD embryos at the expense of lymphangiogenic sprouts
that would otherwise proceed to form the PL string.
Dll4/Notch Promotes Lymphatic Characteristics
In Vitro
To evaluate whether Notch activation in venous ECs could
induce lymphatic properties, we cocultured human umbilical
venous ECs, which express Notch-1, but negligible levels of
Prox-1 (data not shown), with monkey kidney COS cells
expressing Dll4 (COSDll4) or a control vector (COSCTR), and
analyzed by RT-PCR with human gene-specific primers the
expression of lymphatic markers. Expression levels of the
lymphatic markers PROX-1, VEGFR3, LYVE-1, and SOX18 in
COSDll4-activated human umbilical venous ECs were moder-
ately to distinctly elevated (Figure 3). Notably, the expression
levels of EPHRINB2, which is regulated by Notch and has been
implicated in both arterial and lymphatic processes,1,7 and
COUP-TFII, which is expressed in both venous ECs and
LECs,20 were also upregulated; however, levels of other blood
vessel markers (ENDOGLIN, vascular endothelial [VE]-
CADHERIN, and CD31) were not or were only minimally affected
(Figure 3). The upregulation of lymphatic markers was abolished by
treatment of the cells with DAPT, 30 mol/L (data not shown).
Silencing of Dll4 Impairs PL Cell Migration
Along aISVs
From 60 hpf onward, PL cells switch to radial migration and
navigate ventrally and dorsally alongside aISVs, where they
form lymphatic ISVs (LISVs) (supplemental Note I). Because
the TD failed to form in a fraction of Dll4SPL embryos (25%)
despite the presence of a partial PL string, we further explored
whether Notch signaling affects LISV formation. In control
embryos, LISV-PLs (PL cells that formed LISVs) migrated
exclusively along aISVs, suggesting that vISVs are not permis-
sive (Figure 4A and B). Because there were more vISVs and
fewer aISVs in Dll4KD embryos, migrating LISV-PLs were
deprived from their arterial template and could, therefore, not
contribute to TD formation (Figure 4C). This was the most
common migration defect. Intriguingly, even when residual
aISVs formed in Dll4SPL embryos, LISV-PLs sometimes by-
passed the aISV post, failing to turn and migrate along aISVs
(Figure 4D). Indeed, in Dll4SPL embryos with a nearly complete
PL string (90% of its length; meanSEM; N61), 496% of
their aISVs were not accompanied by LISV-PLs, compared with
only 154% in controls (meanSEM; N29; P0.05).
Other, much less frequent, LISV defects included LISV-
PLs that turned ventrally alongside the aISV but stalled
(Figure 4E) or, even in a few cases, misrouted LISV-PLs
Figure 3. Notch activation by Dll4 promotes lymphatic characteris-
tics in vitro. RT-PCR of human umbilical venous ECs (HUVECs),
cocultured with COS cells expressing hDll4 (COSDll4) or control
GFP (COSCTR), confirming upregulation of Notch targets HES1,
HEY1, HEY2, NRARP; blue bars) and revealing enhanced lym-
phatic marker expression (PROX-1, LYVE-1, VEGFR3, SOX18,
EPHRINB2; green bars), whereas vascular genes (CD31,
VE-CADHERIN; ENDOGLIN; red bars) were only minimally affected.
COUP-TFII was also upregulated. NEUROPILIN-2 was not
affected. Lymphatic/arterial and lymphatic/venous genes are
marked by the overlapping dashed lines. Results are fold change
in HUVEC/COSDll4 coculture vs HUVEC/COSCTR. Data are given as
meanSEM; n3 to 11; *P0.05.
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migrating along vISVs (Figure 4F). In vitro studies revealed
that Notch did not regulate LEC migration/motility, prolifer-
ation, or lymphatic capillary tube formation or sprouting
(supplemental Figure V and data not shown).
Expression of Dll4 and Notch
Whole-mount in situ hybridization in control embryos at 30 hpf,
when secondary sprout formation starts, showed that Dll4 was
detectable in the DA but not in the PCV (Figure 5A and B), in
line with previous reports.19,21,22 Notch-1b was strongly ex-
pressed in the DA (Figure 5C and D), whereas a much weaker
signal appeared dispersed in certain ECs of the dorsal part of the
PCV, although the low Notch-1b signal approached the detec-
tion limit of available techniques (supplemental Figure VI).
We also developed a new technique to isolate LECs from
zebrafish embryos. When tetramethylrhodamine B isothiocya-
nate–dextran dye is injected intramuscularly in 4-week-old
Fli1:eGFPy1 embryos, the red dye is taken up by LECs but not
by BECs via pinocytosis, allowing fluorescence-activated cell
sorting of red or green LECs. By RT-PCR, low Notch-1b
transcript levels were detected in these LECs (ratio of copies of
Notch-1b to 105 copies of -actin: 6.900.77; N4). However,
tetramethylrhodamine B isothiocyanate–dextran “LEC label-
ing” is only feasible in large 4-week-old embryos, but not in
small early-stage embryos, precluding us from quantifying
Notch-1b expression in early lymphatic development.
Dll4 and Notch-1b were also detected by in situ hybridization
in primary ISVs at 30 hpf (Figure 5A-C).21,22 Because in situ
hybridization is technically challenging in embryos beyond 2
dpf, we analyzed Notch expression during LISV-PL migration in
Tp1bglob:eGFPxFli1:DsRed fish, in which all ECs are red and
cells with canonical Notch activity are green (GFP driven by a
promoter containing 12 Su[H] binding sequences13). Imaging
when PL cells turn and switch to radial ventral migration
revealed that the DA and aISVs are yellow in the merged image,
indicating that canonical Notch signaling was active in arterial
vessels but not in LISVs or vISVs (Figure 5E–E).
Discussion
The key finding of this study is that incomplete silencing or
pharmacological inhibition of Notch impaired lymphatic
development in zebrafish. Phenotypic analysis indicates that
Notch signaling regulates the formation of lymphangiogenic
sprouts and their descendent PL cells, which produce the TD
(Figure 6A and B). At a later stage, Notch is required for
guided migration of LISV-PLs along aISVs (Figure 6C-C).
Role of Notch in Lymphangiogenic Secondary
Sprout Formation
Our results reveal that Notch, in addition to its role in blood
vessel morphogenesis and arterial development,4,9 also regu-
lates lymphatic development. Half of the Notch hypomor-
Figure 4. Incomplete silencing of Notch
perturbs lymphatic navigation. Confocal
images with accompanying schematic
redrawing of the navigation routes of
LISVs along aISVs or vISVs in 4-dpf con-
trol (A and B) and Dll4KD (C-F)
Fli1:eGFPy1 embryos. Permanent lym-
phatic structures (LISV and TD) are dark
green; and transient lymphangiogenic
structures (PL) are light green. A and B,
In control embryos, LISV-PLs navigate
alongside aISVs and establish a continu-
ous TD (arrowhead). In A, LISVs “creep”
over their aISV guidance templates; in B,
LISV-PLs never navigate along vISVs in
control embryos. C through F, Naviga-
tion defects in Dll4KD embryos. In C, a
large fraction of morphant somites, LISV-
PLs, lack migration templates because
fewer aISVs develop. Because LISV-PLs
do not normally migrate along vISVs, no
TD was formed in these somites (aster-
isks); in D, in other morphant somites,
LISV-PLs bypassed the point of turning
at the aISVs and failed to switch to
radial migration; in E, in a small fraction
of somites, LISV-PLs made the turn and
switched to radial migration, but then
stalled (red arrowhead denotes the
arrested tip of a navigating LISV); and in
F, in most Dll4KD embryos, vISVs were
not permissive to guide LISV-PLs, but,
occasionally, LISV-PLs erroneously navi-
gated alongside a vISV.
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phant embryos failed to form a TD without later rescue,
indicating lymphatic abortion rather than delay. The earliest
identifiable abnormality, the increased fraction of venous
ISVs, indicated a defect at the level of the secondary sprouts
from the PCV, where fewer lymphangiogenic, but more
angiogenic, sprouts developed (Figure 6A and B). Also, most
embryos, surviving DAPT treatment at stages when lym-
phangiogenic sprouting was initiated, did not form a TD,
further suggesting an early role for Notch in lymphatic
development (data not shown). The hypomorphant pheno-
Figure 5. Expression of Dll4/Notch-1b. A
through D, Whole-mount stained
embryos at 30 hpf, when lymphangio-
genic sprouting occurs, stained for Dll4
(A and B) or Notch-1b (C and D). In A
and C, primary ISVs are indicated by
yellow arrowheads; and in B and D,
cross-sections of the respective
embryos are shown. In A and B, Dll4
expression was detected in the DA and
primary aISVs, pronephric duct (white
arrow; A). C and D, Notch-1b is strongly
expressed in the neural tube (NT), DA,
and primary aISVs. E, Confocal images
of Tp1bglob:eGFPxFli1:DsRed embryos,
in which Fli1:DsRed marks blood and
lymph vessels in red (E) and
Tp1bglob:eGFP labels cells with acti-
vated canonical Notch activity in green
(E’). The merged image shows arterial
vessels (DA; aISV) with active Notch in
yellow (green-red), whereas the LISV are
only red (E). In the schematic represen-
tation, the lymphatic structures are indi-
cated in green; Notch-activated vessels,
yellow; and other vessels, gray (E).
Representative images of arterial activa-
tion of Notch in a 6-dpf embryo are
shown (for technical reasons); however,
similar data were obtained at 60 hpf. The
bar indicates 50 m.
Figure 6. Schematic model of Notch in
lymphatic development. Scheme illus-
trating the different lymphatic defects in
Dll4KD embryos (normal lymphatic devel-
opment; supplemental Figure I). Perma-
nent lymphatic structures (LISV and TD)
are dark green; and transient lym-
phangiogenic structures (lymphangio-
genic secondary sprouts and para-
chordal lymphangioblasts), light green. A
and B, Reduced fraction of lymphangio-
genic sprouts, resulting in underdevelop-
ment or absence of the PL string, with
accompanying overrepresentation of
angiogenic secondary sprouts. C
through C, LISV migration defects: as a
result of vISV overrepresentation, LISV-
PLs are deprived of their normal aISV
guidance template (C) and LISV forma-
tion is further impaired by additional nav-
igation defects, most frequently because
LISV-PLs cells bypass their turning point
and never initiate ventral radial migration
(C’) or occasionally make the turn but
then stall (C). More rarely, navigating
LISV-PLs become misrouted along vISVs
(C). The most frequent defects are
boxed in gray.
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typic change correlated with defective formation of the PL
and TD and could result from defects in LEC fate acquisition,
migration, proliferation, survival, and/or other cellular pro-
cesses contributing to sprout formation and maintenance.
How Notch signaling regulates lymphatic development re-
mains unresolved. Based on the present study and other recent
studies, 3 possible (nonexclusive) models can be considered to
explain our findings. A first explanation is that Notch silencing
altered blood vessel development and, secondarily, influenced
lymphatic development. Previous studies documented that arte-
rial differentiation is impaired by inhibition of multiple Notch
signaling pathways (eg, by a dominant-negative Su[H]),7 but not
by selective silencing of Dll4.21,22 Our imaging and marker
expression analyses are consistent with these findings and reveal
that initial formation and differentiation of the PCV, DA, and
primary ISVs all occurred normally on incomplete silencing of
Notch signaling. Thus, at least by generally accepted criteria of
arterial and venous identity, these blood vessels developed
normally in Dll4KD and Notch-1bKD embryos. Nevertheless, we
do not exclude the possibility that subtle alterations in arterial
characteristics of the primary ISVs might have favored super-
numerary connections with secondary sprouts, thereby “entrap-
ping” sprouts that would otherwise have remained lymphangio-
genic. Also, Notch silencing resulted in a greater fraction of
venous than arterial ISVs; because arterial ISVs act as guidance
templates for LISVs, impaired migration of the latter was indeed
attributable to such a change in arterial morphogenesis. How-
ever, an outstanding question is whether the aISV changes
themselves were, in fact, not caused by defective formation of the
lymphangiogenic sprouts in the first instance. Indeed, precisely
because lymphangiogenic branches failed to develop in Notch
morphants, venous angiogenic sprouts formed instead, which then
connected to the primary ISVs and converted them to vISVs.
A second model is that Dll4 and Notch are expressed by the
same or adjacent arterial ECs within the DA and that this cis
signaling induces the release of paracrine lymphangiogenic
factors (eg, EphrinB2, VEGF-D,1,23 or an unknown signal)
that indirectly instruct venous ECs of the nearby PCV to induce
lymphangiogenic sprout formation in a cell nonautonomous
manner. A similar indirect model was proposed to explain
segregation of the DA from PCV in zebrafish.8 Likewise, during
LISV migration, release of a guidance signal from aISVs in
response to Dll4/Notch signaling in arterial cells could assist
navigation of LISVs to their target projection.
Finally, a third and perhaps the most appealing, but at this
stage still speculative, explanation for our data is that arterial
Dll4 in the DA signals in trans to Notch on ECs in the PCV,
which lies in close juxtaposition at the time of lymphangiogenic
sprouting. There are arguments in support of and against this
model. An argument in favor of a cell autonomous role of Notch
in PCV cells is that activation of Notch by Dll4 upregulated
several LEC-specific markers in venous ECs in vitro. Expression
analysis experiments in vivo yielded inconclusive results.
Notch-1b expression was weakly detectable in dispersed dorsal
PCV cells, but only at a low level that approached the detection
limit of the techniques used. Notch-1b was also measurable by
RT-PCR in isolated LECs in older embryos; however, this
technique could not be used during early lymphatic develop-
ment. Therefore, we acknowledge that the Notch-1b expression
results represent a limitation of this study that precludes us from
drawing firm conclusions regarding a cell-autonomous role for
Notch in lymphangiogenic sprouting.
Another recent study24 also documented a cell-autonomous
role for Notch, whereas a second study25 did not document this
role. In LEC cultures, Notch signaling reprogrammed lymphatic
to arterial cell fate, whereas Prox-1 counteracted this force,
thereby allowing fine-tuning of the LEC fate in a delicately
balanced feedback.24 These findings are not necessarily contra-
dictory to our findings because they analyzed reprogramming of
fully differentiated LECs away from their lymphatic fate; we
used venous BECs to study programming toward the LEC fate
in vitro. Kang et al24 note in their discussion that “LEC-fate may
not be governed by a two-way turn on-off switch, but rather by
a dial switch that allows a gradient increase or decrease in the
lymphatic cell fate force.” Reconciling these and our findings, it
seems that Notch levels must be tightly controlled to induce and
maintain LEC fate. Low levels of Notch signaling might be
required to induce lymphatic fate in venous BECs; once differ-
entiated into LECs, Prox-1 would then secure lymphatic fate by
preventing overexpression of Notch because this would promote
arterial cell fate.24 The lower expression of Notch-1 in LECs (as
found in the present study and in previous studies10,24) than in
arterial ECs8–11 supports this model and could also explain why
incomplete Notch silencing sufficed to abrogate lymphatic, but
not arterial, development. However, in the absence of more
conclusive evidence that Notch silencing abrogates Prox-1
induction in PCV cells in the zebrafish model in vivo, a role for
Notch in programming LEC fate remains unproved. Also, Notch
may regulate processes other than LEC specification in lym-
phangiogenic sprouting.
A recent study in mice further adds complexity to this
model. Indeed, conditional inactivation of RbpJ, a mediator
of canonical Notch signaling, in ECs did not alter the
expression of lymphatic markers in venous ECs.25 Although
these data may suggest that Notch signaling is redundant for
LEC specification in mammals in vivo, an alternative inter-
pretation is that Notch regulates this process via noncanonical
signaling. This might also explain why we could not detect a
robust signal in LECs or in their precursors in the
Tp1bglob:eGFPxFli1:DsRed line. Also, species-specific dif-
ferences between mammals and zebrafish could account for
some of the observations. Overall, whether Notch signaling
regulates lymphatic development in a cell-autonomous man-
ner remains to be further elucidated in the future.
Role of Notch in Lymphatic Migration From the PL
Notch signaling also regulated the formation of LISVs, which
arise from the PL cells. Most frequently, the LISV was absent;
however, in other rarer cases, migrating LISV-PLs stalled or
became misrouted (Figure 6C-C). Our findings suggest that
lymphangiogenic EC migration per se (motility) was normal.
Also, we did not detect signs of lymphatic regression or
retraction (data not shown). Therefore, it is tempting to speculate
that LISV defects in Notch-silenced embryos reflect impaired
lymphangiogenic cell pathfinding. LISV-PLs navigated in close
association along aISV templates, raising the question of
whether aISVs act as guidance templates for LISV-PLs, remi-
niscent of how follower axons navigate along a pioneer axon’s
Geudens et al Notch in Lymphangiogenesis 1701
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pathway or how autonomic nerves use arterial tracks to reach
their target.26,27 Therefore, because fewer aISVs are present in
Notch morphants as the result of lymphangiogenic sprouting
defects, PL cells are deprived of navigation templates and,
therefore, cannot form LISVs normally (Figure 6C). Other
observations that LISV-PLs failed to switch from tangential to
radial migration or, more rarely, stalled or selected incorrect
paths (Figure 6C’-C) are reminiscent of classic neuronal
guidance defects. That arteries may act as navigation templates
is evidenced by reports that autonomic nerves stall or become
misrouted when these arteries do not produce appropriate guid-
ance cues.27 Su[H]-dependent Notch activity was detectable in
aISVs when PL cells switch from tangential to radial migration
alongside aISV, indicating that lymphatic navigation is regulated
either cell nonautonomously or via noncanonical Notch signal-
ing. Whether and how Notch regulates the production of turning
and guidance cues for LISV-PL cells by aISVs or nearby
(somitic) cells remain to be determined. Other morphant and
mutant zebrafish phenotypes also suggest that LISV develop-
ment requires arterial-lymphatic congruence.28
In conclusion, this study revealed a role of Notch in lymphatic
development, in part by regulating the initial steps of lym-
phangiogenic sprouting and PL formation. Moreover, the navi-
gation defects of LISV-PL cells along aISVs suggest that Notch
also regulates lymph vessel pathfinding along arteries.
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SUPPLEMENTAL MATERIAL  
 
ROLE OF DLL4 / NOT CH IN THE FORMATION AND WIRING 
OF THE LYMPHATIC NETWORK IN ZEBRAFISH 




SCREENING METHODS FOR EVALUATION OF LYMPHATIC DEVELOPMENT AND 
FUNCTIONALITY 
SCORING OF TD AND PL STRING FORMATION IN ZEBRAFISH: Live screening and 
quantification of thoracic duct (TD) formation was performed on anaesthetized 
Fli1:eGFPy1 embryos (a few drops of 4 mg/ml Tricaine (Sigma) stock solution in 5 ml 
embryo water) at 6 dpf when this vessel was completely developed in control 
embryos. DAPT treated fish (see below) were screened at 4 dpf, since screening at 
6 dpf became impossible because fish became opaque due to loss of trunk 
circulation and edema and many fish died between 4 and 6 dpf. For screening, 
images were acquired using Zeiss AxioVision 4.6 software on a Leica DM RBE 
fluorescence stereomicroscope equipped with a Zeiss AxioCam MrC5 digital camera 
(Carl Zeiss, Munich, Germany; Leica Microsystems, Wetzlar, Germany). For reasons 
of standardization and to correct for slight differences in embryo size, the percentage 
of thoracic duct formation was quantified by scoring its percentile presence in 10 
consecutive somite segments in the trunk after the junction of DA and PCV (i.e. 
somites 5-15, see Supplemental Figure III E). For screening of thoracic duct 
formation, only embryos with normal overall morphology and normal trunk circulation 
were included. All data are based on scorings of 33-185 embryos per condition, 
generated in at least 3 independent experiments. All analyses were performed by 
investigators blinded for the experimental treatment. Because the penetrance of the 
lymphatic phenotype was variable (see Supplemental Note II), we also determined 
the fraction of embryos with severe, intermediate or subtle lymphatic defects for each 
 at UNIV MEDECINE LEIG 228272 on January 24, 2012http://atvb.ahajournals.org/Downloaded from 
 2 
treatment dose. Since parachordal lymphangiobast (PL) cells develop initially from 
lymphangiogenic secondary sprouts in a segmented pattern (Supplemental Figure 
I),1 screening of PL string formation in the 10-somite segment of the trunk was 
performed in a similar manner at 52 hpf. Confocal imaging of Fli1:eGFPy1 embryos 
was performed using a Zeiss laser scanning microscope LSM510 or Leica SP2, SPE 
and SP5 confocal microscopes. Embryos were anaesthetized and positioned on a 
coverslip in a drop of 0.5% low melting point agarose. Fluorescence signal of 
Stab1:YFP images was transformed to a gray-scale image for better contrast.  
FUNCTIONAL ASSESSMENT OF THE THORACIC DUCT: For functional studies, anesthetized 
larvae were subcutaneously injected with 1 nl fluorescent dextran (2.5 mg/ml) into 
the muscle mass of the posterior trunk by using glass capillaries and a conventional 
microinjection setup.2  
IN VIVO “LEC-LABELING” AND FACS SORTING OF LABELED LECS: LEC labeling was 
performed on anaesthetized (a few drops of 4 mg/ml Tricaine (Sigma) stock solution 
in 5 ml embryo water) Fli1:eGFPy1 zebrafish larvae of 4 weeks old. Tetramethyl-
rhodamine-dextran (TRITC-dextran; molecular weight 2000 kDa) was injected 
intramuscularly into the tail somites. After 3-4 days the dye had been drained by the 
lymphatics and was taken up by the LECs through pinocytosis. To obtain single cell 
supspensions, tails of at least 10 LEC labeled fish were collected, washed with 
distilled water, chopped, and incubated in 0.25% trypsin at 28°C until almost 
completely digested. The reaction was stopped by addition of 100µl FCS to inhibit 
the trypsin and the cell suspension was loaded on top of a Cell strainer tube with 
blue filter cap (40µm; BD Biosciences) for filtration. After pelleting of the cells (5min, 
200g), the cell suspension was washed with 1ml dPBS containing 2% FCS, and 
viable cells were counted using trypan blue exclusion. After pelleting the cells were 
resuspended at a concentration of 106 cells/ml in FACS buffer (dPBS containing 1% 
FCS, filtered). Cells were sorted using a FACSAria (Becton Dickinson), taking care 
to exclude possible doublets or cell clusters. Non-injected GFP+ Fli1:GFPy1 and 
TRITC-dextran injected GFP- embryos were used as controls for proper 
compensation and gate setting. On average 25000 GFP+TRITC+ LECs and 50000 
GFP+TRITC- BECs were sorted directly in lysis buffer (RLT containing 1% β-
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mercaptoethanol) and processed for RNA extraction using the RNeasy kit (qiagen).  
TIME LAPSE IMAGING: Embryos were mounted in 0.5% low melting point agarose in a 
culture dish with a cover slip replacing the bottom. Imaging was performed with a 
Leica SP2 or SP5 confocal microscope using a 10x, 20x or 40x objective with digital 
zoom. Timelapse analysis was compiled using ImageJ software 
(http://rsb.info.nih.gov/ij/). Time points were recorded every 10 minutes for the stated 
time period. A heated stage maintained the embryos at approximately 28.3 °C.  
WHOLE-MOUNT IN SITU HYBRIDIZATION: Antisense probes specific for zebrafish 
EphrinB2a,3 Vegfr3,4 Notch-1b, Notch-6, Dll4, Tie2, Dab2,1, 5 Tbx20,6 Cmlc2 or MyoD 
were used for whole-mount in situ hybridization of 28-48hpf embryos as described.7 
Stained embryos were paraffin- or plastic-embedded, sectioned and counterstained 
with nuclear fast red. In all figure panels the head of the embryo faces left and dorsal 
is up, unless stated otherwise. 
QUANTITATIVE RT-PCR EXPRESSION ANALYSIS: RNA from FACS sorted LECs was 
reverse transcribed using the SuperScriptIII kit from Ambion. RNA from whole 
embryos was obtained by lysing in Trizol reagent and extraction using the RNeasy 
MiniElute Cleanup kit (Qiagen) and cDNA was prepared using the Quantitect 
Reverse Transcription kit (Qiagen). cDNA was subjected to qRT-PCR using 
zebrafish gene-specific primers/probe sets (Table S2). 
CELL CULTURE EXPERIMENTS 
HUVEC cells (Lonza, Invitrogen, Merelbeke, Belgium) and HUVEC/COS co-cultures 
were grown in EGM2-MV medium (Lonza, Invitrogen) at 37°C. COS cells were 
grown in standard DMEM medium (Lonza, Invitrogen) supplemented with 10% FBS, 
2 mM glutamin, 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Lonza). 
COCULTURE ASSAY: COS cells stably expressing full length human Dll4 (COSDll4) or 
expressing GFP (COSCTR) were prepared using the retroviral constructs 
LZRSpBMN-DLL4 and LZRSpBMN-WT, respectively.8 HUVECs were co-seeded 
with COSDll4 or COSCTR cells in 6-wells at a density of 200,000 cells each, grown for 
24 hours and harvested for RNA analysis by quantitative RT-PCR using human 
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gene-specific primers (Table S2). PROLIFERATION ASSAY: Primary LEC (HMVEC-DLy 
or HMVEC-LLy; Lonza, Invitrogen) were starved overnight in EGM2 medium (Lonza, 
Invitrogen) containing 0.1% serum and no growth factors (starvation medium). The 
starved cells were seeded at 2,000 cells per well in 96-well microtiter plates, after 
which proliferation was induced with fully supplemented EGM2-MV medium with or 
without increasing concentrations of DAPT (20-60 µM). Proliferation was measured 
as the number of viable cells after further culturing for 48 hours, expressed in % of 
DMSO control. Viable cells were quantified using the Rapid Cell Proliferation assay 
(Calbiochem, San Diego, CA).  
SCRATCH WOUND MIGRATION ASSAY: Confluent monolayers of LECs growing in 0.1% 
gelatin-coated wells of a 24-well plate were starved overnight, pretreated in 
starvation medium containing 30 µM DAPT or 0.3% DMSO (control), scratch 
wounded and photographed (T0). The cells were further incubated for 24 hrs and 
photographed again (T24). Migration distance (gap width at T0 minus gap width at 
T24; 10 measurements per wound at regular intervals along the wound) was 
determined by image analysis using KS300 morphometry software, and is expressed 
relative to the control (DMSO).  
TRANSWELL MIGRATION ASSAY IN CONDITIONS OF NOTCH INHIBITION: LECs were 
pretreated with DAPT (60 µM) or vehicle (DMSO) in starvation medium overnight, 
seeded at 30,000 cells per transwell on 0.1% gelatin-coated transwells in starvation 
medium with DAPT or DMSO, and cultured for 2 hours until adherence. Migration 
was induced by transferring the transwell insets into wells (bottom well) containing 
fully supplemented EGM2-MV medium with 100 ng recombinant human VEGF-C 
(Reliatech, TecoMedical NL, Nijkerk, the Netherlands), and DAPT or DMSO. 
Background migration was determined by including transwells with starvation 
medium in both the top and bottom well (baseline). After culturing for 16 hours, the 
non-migrated cells on the top side of the transwell filters were wiped off using PBS-
soaked cotton swabs, and the transwells were fixed with 1% p-formaldehyde. The 
transwell filters were cut out and mounted upside-down on micrsocope slides with 
DAPI containing mounting medium. The filters were photographed under DAPI 
fluorescence at 20x magnification, and the nuclei were counted as a measure of 
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migrated cells. Five transwells were prepared per condition and five optical fields 
were counted and averaged per transwell filter.  
TRANSWELL MIGRATION ASSAY IN CONDITIONS OF NOTCH ACTIVATION: LECs were starved 
overnight and seeded at 30,000 cells per transwell on transwell filters coated with 
BSA or with the extracellular domain of Dll4 (Dll4-ECD; R&D Systems Europe Ltd., 
Abingdon, UK) to activate the Notch pathway as described.9 Further manipulation 
was as described above, using starvation medium in all top wells and fully 
supplemented medium containing VEGF-C in all bottom wells except for the baseline 
conditions. The filters were photographed under DAPI fluorescence at 10x 
magnification, Five transwells were prepared per condition and 1 central optical field 
was counted per transwell filter.  




SUPPLEMENTAL NOTE I: LYMPHATIC DEVELOPMENT IN ZEBRAFISH EMBRYOS 
In zebrafish embryos, the thoracic duct (TD) develops between the dorsal aorta (DA) 
and posterior cardinal vein (PCV); it is considered to be the first perfused lymphatic, 
as it drains interstitial dyes and has structural characteristics closely resembling 
mammalian lymphatics.2, 10, 11 For reasons of clarity, formation of this early lymphatic 
network is schematically illustrated in Supplemental Figure I. Around 30 hpf, half of 
the secondary sprouts from the PCV, on average one per two unilateral somite 
segments, migrate radially in the ventral-dorsal direction to the horizontal 
myoseptum; these sprouts exist transiently (Supplemental Figure I A,A’,B,B’).1, 12 At 
the horizontal myoseptum, cells of these sprouts then migrate tangentially in the 
anterior-posterior direction to form a string of parachordal lymphangioblasts (PL), 
which act as progenitors of future LECs in the TD (36 to 60 hpf); the PL string also 
exists only transiently. Since the secondary sprouts from the PCV, which give rise to 
the PL, participate in the process that leads to the formation of the TD, they have 
been termed “lymphangiogenic secondary sprouts”. Indeed, the lymphangiogenic 
sprouts and PL cells give rise only to lymphatics but not to blood vessels, are not 
labeled in the arterial/venous kdr-l:mCherryRed marker line,1 and fail to form upon 
silencing of genes that regulate lymphangiogenesis in mice and humans, e.g., 
Ccbe1,1, 13 Vegf-c,1 Vegfr-314 and Synectin (unpublished). The other secondary 
sprouts connect to the primary intersomitic vessels (ISVs), which thereby become 
intersomitic veins (vISV), and have therefore been termed “angiogenic secondary 
sprouts” (Supplemental Figure I A,B).1, 12  
From 60 hpf onwards, the PL cells switch to radial migration again, and navigate 
both ventrally and dorsally alongside arterial intersomitic vessels (aISVs), whereby 
they form structures, that later persist as lymphatic intersomitic vessels (LISVs) 
(Supplemental Figure I C,D).1 These radially migrating cells are termed LISV-PLs to 
distinguish them from the cells in the PL string. Once ventrally migrating LISV-PLs 
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reach their final location in-between the DA and PCV, they switch again to tangential 
migration, grow towards each other and fuse to establish the TD (3 to 6 dpf) 
(Supplemental Figure I D,D’).1, 2, 11, 12 While lymphangiogenic secondary sprouts 
migrate at a distance from and independently of aISVs, LISVs always navigated 
alongside aISVs, almost “creeping” over them in their initial dorsal and ventral 
trajectory, but never track alongside vISVs (Supplemental Figure I A’,B’,D’). This 
close association of LISVs with aISVs raised the question whether aISVs act as 
guidance templates for navigating LISVs-PLs.  
 
SUPPLEMENTAL NOTE II: SILENCING STRATEGIES TO STUDY THE ROLE OF NOTCH IN 
LYMPH VESSEL FORMATION 
SILENCING STRATEGIES: To explore a role for Notch signaling in lymphatic 
development, we made use of morpholino antisense oligonucleotides to silence 
every known zebrafish orthologue of the Notch ligands (DeltaA-D, Dll4, Jagged-1a/b, 
Jagged-2) and receptors (Notch-1a/b, -5, -6) as well as of the Notch activating 
presenilins (PS-1 and PS-2). For reasons of consistency, we used the zebrafish 
nomenclature: zebrafish Notch-5 and -6 are mammalian homologues of Notch-3 and 
-2, respectively, while zebrafish Notch-1a and -1b are duplicated mammalian 
orthologues of Notch-1.15 Alternatively, Notch receptor activation was inhibited by 
exposing dechorionated 24-hpf embryos to N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-
phenylglycine t-butyl ester (DAPT), a well known γ-secretase inhibitor (γ-secretase 
inhibitor IX; Calbiochem), that has been previously used to block Notch signaling in 
zebrafish embryos.16  
SPECIFICITY OF THE PHENOTYPES: As Notch-family members have been implicated in 
angiogenesis,17-19 we used submaximal doses of all morpholinos or of compound 
inhibitor to minimize secondary effects of vascular malformations on lymphatic 
development (referred to as “incomplete silencing” and “Notch hypomorphants”; 
Supplemental Figure II A-H and not shown). Furthermore, the compound inhibitor 
DAPT was added at later developmental stages, to avoid defects in early vascular 
development. We experimentally determined that treatment initiation at 43 hpf 
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induced lymphatic defects without inducing major vascular and developmental 
malformations. Treatment at earlier stages induced blood flow arrest, hemorrhages 
and edema in the majority of treated embryos. Only morphant embryos with a normal 
size, trunk circulation and blood flow, and without developmental delay, tissue 
malformations, general edema or toxic defects were included (Supplemental Figure 
III A-D; not shown). The lymphatic defects upon knockdown or compound treatment 
indeed were specific, as no overt changes in the formation and differentiation of the 
DA and PCV were noticeable (Supplemental Figure IV). Consistent with previous 
reports,14, 20 some hyperbranching of the primary ISVs was detected in Dll4KD 
hypomorphant embryos, but to a variable degree and in only 20% of Dll4KD embryos 
(red arrowheads in Figure 1B; Supplemental Movie II). Also, no abnormalities in 
heart or somite development were observed (Supplemental Figure II I-L).  
PHENOTYPE PENETRANCE: We speculate that the variably penetrant lymphatic 
phenotypes and spectrum of defects in the Notch hypomorphants is due to a 
combination of reasons, including the use of a submaximal dose of morpholino 
(incomplete silencing), technical limitations of injecting an identical dose of 
morpholino, genetic differences of the morphant embryos analyzed (outbred 
background; 10-fold variable RNA expression levels were observed for Dll4 between 
individual 4-dpf old embryos (copies Dll4/105 copies β-actin, median (range): 23.4 (6 
– 58); N=24), uneven dispersion of morpholinos upon daughter cell division, and 
variable timing of venous/lymphatic secondary sprout formation along the PCV 
(occurring within a time window of 30 to 50 hpf 1). As a result, achieving the 
necessary degree of silencing below the critical biological threshold at the distinct 
sprouting locations along the PCV becomes stochastic in such experimental 
conditions.  
Phenotypic defects were dose-dependent, but for reasons of brevity, only the highest 
dose is shown. A standard control morpholino was used routinely and results were 
confirmed by using a second independent target-specific morpholino for silencing of 
Dll4, Notch-1b and PS-1.  
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SUPPLEMENTAL NOTE III: ACRONYMS FOR VASCULAR AND LYMPHATIC STRUCTURES IN 
THE ZEBRAFISH MODEL 
aISV: arterial intersomitic vessel 
BEC:  blood endothelial cell 
DA: dorsal aorta 
DLAV:  dorsal longitudinal anastomosing vessel 
DLLV:  dorsal longitudinal lymphatic vessel 
ISV: intersomitic vessel 
LEC:  lymphatic endothelial cell 
LISV: lymphatic intersomitic vessel 
LISV-PL: parachordal lymphangioblasts that form the LISV 
PAV:  parachordal vessel 
PCV: posterior cardinal vein 
PL: parochordal lymphangioblast 
TD: thoracic duct 
vISV:  venous intersomitic vessel 
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SUPPLEMENTAL FIGURES and MOVIES 
 
SUPPLEMENTAL FIGURE I: MODEL OF LYMPHATIC DEVELOPMENT IN ZEBRAFISH EMBRYOS 
In all panels, a schematic figure is shown on the left, and for panel A,B,D a high-
magnification image of the blood and lymphatic vasculature at different stages of 
development in Fli1:eGFPy1 zebrafish on the right. For clarity, the confocal images 
are flanked by redrawings of the vessel contours. DA, dorsal aorta; DLAV, dorsal 
longitudinal anastomosing vessel; DLLV, dorsal longitudinal lymph vessel; ISV, 
intersomitic vessel; aISV, arterial ISV; LISV, lymphatic ISV; vISV, venous ISV; PCV, 
posterial cardinal vein; PL, parachordal lymphangioblast string; TD, thoracic duct. 
Permanent lymphatic structures (LISV, TD) are labeled dark green; transient 
lymphangiogenic structures (lymphangiogenic secondary sprouts; PL cells) are 
labeled light green. A,A’, From around 30 hpf onwards, secondary sprouts arise from 
the PCV. About half of them will give rise to lymphatic structures and are therefore 
named lymphangiogenic secondary sprout (Ly sec. sprout; yellow arrows in A’). The 
other half of the secondary sprouts remain venous in nature (angiogenic secondary 
sprouts) (blue in A). B,B’, By 48 hpf, the lymphangiogenic sprouts (yellow arrows in 
B’) radially migrate dorsally to the level of the horizontal myoseptum, where they 
migrate tangentially to give rise to a transiently existing string of PL cells. The 
angiogenic sprouts connect to the aISV (red), which thereby will acquire a venous 
identity. C, Around 60 hpf, PL cells turn and switch from tangential to radial migration 
closely along aISVs, thereby forming lymphatic intersomitic vessels (LISVS); note the 
close association of LISVs with aISVs. LISVs that ascend form the dorsal longitudinal 
lymph vessel (DLLV), while those that descend form the TD. ISVs that connected to 
the angiogenic secondary sprouts progressively loose their arterial identity and 
acquire a venous fate. D,D’, From 3 days onwards, the first TD fragments appear at 
distinct locations along the trunk and, via tangential migration, extend rostrally and 
caudally to merge into a complete TD. The LISV and TD are indicated by white 
arrows and arrowhead, respectively, in D’. 
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SUPPLEMENTAL FIGURE II: DEVELOPMENT OF EMBRYOS UPON INCOMPLETE INHIBITION 
OF DLL4 
Complete silencing of Dll4/Notch signaling causes pronounced angiogenic defects.17, 
18, 21, 22 We therefore performed a detailed analysis, using high-resolution imaging, of 
the vasculature of control (A,C,E,G) and Dll4KD hypomorphant Fli1:eGFPy1 embryos 
(10 ng Dll4SPL; B,D,F,H). Scale bars: 100 µm. DA, dorsal aorta; PAV, parachordal 
vessel; PCV, posterior cardinal vein; TD, thoracic duct. A,B, The early vasculogenic 
stages proceeded normally in morphant embryos, resulting in the formation of 
properly sized and shaped axial vessels at timely developmental stages. Knockdown 
of Dll4 did not affect the timing or pathfinding of primary ISVs, or the subsequent 
formation of the DLAV (arrows) in embryos at 30 hpf. The DA is indicated by a red 
vertical bar, while the PCV is denoted by a blue vertical bar. C,D, Close-up images of 
the head vasculature at 30 hpf, showing similar appearance in control and Dll4KD 
embryos. The arrow denotes the mid-cerebral vein. E,F, The subintestinal vessels 
(arrows) in 3-dpf Dll4KD embryos displayed a largely comparable network 
morphogenesis with only minimal signs of hyperbranching. G,H, Image of a 12-dpf 
embryo, revealing that knockdown of Dll4 did not prevent the formation of the PAV, 
which develops only after the TD is established. Note the absence of the TD in the 
morphant embryo (asterisks in panel H), indicating that the TD defect persisted and 
was not rescued over time. The yellow arrowheads in G denote the course of the TD 
in the control embryo. The red arrowheads in H denote mild hyperbranching of the 
ISVs in the Dll4KD embryo. I-L, Whole-mount in situ stainings for Cmlc2 (I,J; 30 hpf) 
and MyoD (K,L; 48 hpf), showing that size and positioning of the heart (arrow) and 
somite development are normal in Dll4KD embryos. Overall, at the morpholino 
concentrations used in our analyses, no overt angiogenic malformations were 
detected in Dll4KD embryos prior to or during lymphangiogenesis. Further, imaging of 
the Flt1:YFP reporter line, in which only arterial ECs are labeled, confirmed that 
primary aISVs expressed the YFP transgene in Dll4KD embryos, indicating that their 
initial arterial specification occurred normally (see Supplemental Movie II).  
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SUPPLEMENTAL FIGURE III: GENERAL MORPHOLOGY AND ANALYSIS OF TD FORMATION 
A-D, Bright field images of 6-dpf control (A), Dll4KD (10 ng Dll4SPL; B), Notch-1bKD (15 
ng Notch-1bSPL; C) and Notch-6KD (15 ng Notch-6SPL; D) embryos, showing normal 
overall morphological development. Only morphant embryos with a normal trunk 
circulation and body size, without developmental delay, tissue malformations, 
general edema or toxic defects were included in TD screening assays. E, TD 
quantification. DA, dorsal aorta; DLAV, dorsal longitudinal anastomosing vessels; 
ISV, intersomitic vessel; PCV, posterial cardinal vein; PL, parachordal 
lymphangioblast string; TD, thoracic duct. TD formation was quantified by measuring 
the length over which it formed in 10 consecutive somite segments (i.e. somites 5-
15; demarcated by the green rectangle). Confocal images of control and morphant 
Fli:eGFPy1 embryos are depicted in the insets. Inset a: in the control embryo, a 
continuous TD formed over all 10 somite segments (100% TD formation; green 
arrowheads). Inset b: severely morphant embryo, in which the TD formed over only 
10% (green arrowhead). Inset a’ and b’: schematic redrawing of the DA, TD and 
PCV in the embryo shown in inset a and b, respectively, with the TD or TD segment 
marked in green. Scale bars: 200 µm in A-D, 100 µm in E and insets of E.  
SUPPLEMENTAL FIGURE IV: NORMAL ARTERIAL-VENOUS DIFFERENTIATION AFTER 
INHIBITION OF NOTCH.  
A-R, Arterial-venous differentiation of the large axial vessels was evaluated upon 
incomplete silencing of the components of the Dll4/Notch signaling pathway that 
were shown in this study to affect lymphatic development. Therefore, whole-mount 
embryos were in situ stained for arterial (EphrinB2a; Tbx20 6, 23) and venous (Vegfr3; 
Dab2 5, 24) markers in control embryos (A-D) and in Dll4KD (10 ng Dll4SPL; E-H), 
Notch-1bKD (15 ng Notch-1bSPL; I-L), Notch-6 (15 ng Notch-6SPL; M,N), PS-1 (15 ng 
PS-1ATG1; O,P) or DAPT-treated (25 µM; Q,R) hypomorphant embryos. Staining was 
performed at 28 hpf (few hours prior to secondary sprout formation) for EphrinB2a, 
Vegfr3 and Tbx20, and at 48 hpf for Dab2, when arterial and venous differentiation of 
the DA and PCV were completed. Overall, expression of arterial markers in the DA 
and of venous markers in the PCV was comparable in control and morphant 
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embryos. Also, note that there is no ectopic expression of these markers. The DA is 
indicated by a red vertical bar, while the PCV is denoted by a blue vertical bar. DA, 
dorsal aorta; PCV, posterior cardinal vein. Scale bar, representative for all panels: 
100 µm.  
 
                 
SUPPLEMENTAL FIGURE V: INHIBITION OF NOTCH DOES NOT AFFECT IN VITRO 
PROLIFERATION AND MIGRATION.  
A, Primary LECs of dermal (HMVEC-DLy) and lung (HMVEC-LLy) origin were 
starved overnight, after which proliferation was induced with full growth medium with 
or without increasing concentrations of DAPT (30-60 µM). Proliferation was 
measured as the number of viable cells after further culturing for 48 hours, 
expressed in % of control. B, Migration of LECs, analyzed using a scratch wound 
healing assay, was not inhibited by DAPT (30 µM). C, Transwell migration of LECs in 
response to culture medium containing 10% FBS and 100 ng/ml VEGF-C in the 
lower compartment (“stimulated”) was not affected by DAPT (60 µM). D, Transwell 
migration of LECs in response to culture medium containing 10% FBS and 100 ng/ml 
VEGF-C in the lower compartment was comparable, when cells were seeded on 
filters coated with BSA (control) or the extracellular domain of Dll4 (Dll4-ECD), 
previously shown to activate Notch signaling.9 Error bars represent SEM; N=5-11. 
 
            
SUPPLEMENTAL FIGURE VI: EXPRESSION OF NOTCH-1B.  
Sagital section of an embryo at 30 hpf, when lymphangiogenic sprouting occurs, 
whole-mount stained for Notch-1b. DA, dorsal aorta; ISV, intersomitic vessel; PCV, 
posterior cardinal vein. Scale bar: 50 µm. Notch-1b is expressed in the DA and ISVs. 
A weak signal can be observed in the dorsal part of the PCV. 
 
SUPPLEMENTAL MOVIE I: NORMAL FORMATION OF ARTERIAL AND VENOUS ISVS IN 
CONTROL EMBRYOS.  
Confocal time-lapse video-imaging analysis of a control Flt1:YFPxkdr-l:mCherryRed 
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reporter embryo from 32 to 72 hpf (representative movie of >100 embryos analyzed), 
in which venous cells are red (CherryRed+) and arterial cells yellow 
(YFP+CherryRed+). Imaging revealed normal progressive ventral-to-dorsal loss of the 
arterial YFP colour in approximately half of the ISVs, once connected by angiogenic 
secondary sprouts of the PCV. For instance, the second and third primary ISV 
(numbering according to the location at the start of the movie) retain their connection 
with the DA as well as their yellow arterial colour, and are thus arterial. In contrast, 
the fourth and fifth ISV loose their connection with the DA as well as their yellow 
arterial colour, progressively become red after establishing a connection with the 
PCV, and thus become venous ISVs.  
Note: This Flt1:YFPxkdr-l:mCherryRed reporter does not label lymph vessels. 
However, since lymphangiogenic secondary sprouts emanate from the PCV 
(CherryRed+) and the CherryRed protein is only degraded after some time, the 
presence of these lymphangiogenic secondary sprouts and of the PL cells is also 
transiently visible. For instance, around 40 hpf, red lymphangiogenic secondary 
sprouts can be seen adjacent to the second and third ISV. These secondary sprouts 
do, however, not connect to the primary ISVs, but migrate dorsally to the horizontal 
myoseptum, where they then migrate tangentially and form the PL string. The 
lymphangiogenic nature of the PL string is illustrated by the gradual loss of its 
residual mCherryRed colour beyond 52 hpf; this is not due to regression of the PL 
cells, since this string disappears only around 4 dpf, i.e. after giving rise to the LISVs 
(not visible in this reporter line) that descend ventrally to the level between the DA 
and PCV to form the TD. DA, dorsal aorta; PCV, posterior cardinal vein; PL, 
parachordal lymphangioblast string; TD, thoracic duct. 
SUPPLEMENTAL MOVIE II: ARTERIAL-TO-VENOUS SHIFT OF ISVS IN DLL4KD EMBRYOS  
Confocal time-lapse video-imaging analysis of a Dll4KD Flt1:YFPxkdr-l:mCherryRed 
embryo from 32-72 hpf (representative movie of >100 embryos analyzed), in which 
venous cells are red (CherryRed+) and arterial cells yellow (YFP+CherryRed+). 
Imaging revealed progressive ventral-to-dorsal loss of the arterial YFP colour in all 
primary ISVs, when they became connected by an angiogenic secondary sprout and 
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therefore adopted a venous fate. In this embryo, there was a shift of 
lymphangiogenic to angiogenic secondary sprouting in all somites imaged.   
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SUPPLEMENTAL TABLE I: MORPHOLINO OLIGONUCLEOTIDE SEQUENCES  
 
MO MO sequence Target Ref 
DeltaAATG 5’-CGCCGACTGATTCATTGGTGGAGAC-3’ Start site  
DeltaBATG 5’- CGCCATCTCGCTCACTTTATCCTAA-3’ Start site  
DeltaCATG 5’- GCACGTTAATAAAACACGAGCCATC-3’ Start site  
DeltaDATG 5’- AACAGCTATCATTAGTCGTCCCATG-3’ Start site  
Dll4ATG 5’-GAGAAAGGTGAGCCAAGCTGCCATG-3’  Start site  




Jag1aATG 5’-GTCTGTCTGTGTGTCTGTCGCTGTG-3’ 5’ UTR  
Jag1bATG 5’-CTGAACTCCGTCGCAGAATCATGCC-3’ Start site  
Jag2ATG 5’-TCCTGATACAATTCCACATGCCGCC-3’ Start site  
Notch-1aATG 5’-TTCACCAAGAAACGGTTCATAACTC-3’ Start site 25, 26 
Notch-1bATG 5’-ATGCATTCCTTCTTATGGATAGTCC-3’ Start site  
Notch-1bSPL 5’-AATCTCAAACTGACCTCAAACCGAC-3’ intron28/exon29  20, 27 
Notch-5ATG 5’-ATATCCAAAGGCTGTAATTCCCCAT-3’ Start site 20, 28 
Notch-6SPL 5’-AGGTGAACACTTACTTCATGCCAAA-3’ exon7/intron7  20, 28 
PS-1ATG1 5’-CCGGGATCATAGAAACAGCGGGAAC-3’ 5’ UTR  
PS-1ATG2 5’-CATTCTGCACTAAATCAGCCATCGG-3’ Start site  
PS-2ATG 5’-CTCTTCACTGTCTGAGGTATTCATG-3’ Start site 29 
control MO 5'-CCTCTTACCTCAGTTACAATTTATA-3' Standard control MO (Gene Tools)  
For the previously unpublished morpholinos, silencing efficiencies of morpholinos 
directed against the ATG region were confirmed using a luciferase reporter assay, as 
previously described 30 (not shown). 
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5’-AAC AAC CAA GAT CTT TCC CAT ATA CA-3’ 
5’-GCT CTA GCC ATT CGC ATT GAC-3’ 




5’-CTT CAC CGG ACC CCT CTG T-3’ 
5’-TGG AAG CGG TCT TGA GTT TCT C-3’ 




5’-TGG TAT GGG ACA GAA AGA CAG CT-3’ 
5’-TTG GGT ACT TCA GGG TCA GGA-3’ 
5’-FAM-TCT TGC TCT GAG CCT CAT CAC CAA CG-TAMRA-3’ 
Human genes 
HES1 Hs00232622_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 
HEY1 Hs00232618_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 
HEY2 Hs00232622_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 





5’-TTC CTG GCT TCC CGA AAG T-3’ 
5’-AGG CCA AAG TCA CAG ATC TTC AC-3’ 




5’-GTG CTT TGG CGA CGT CAT C-3’ 
5’-TCA GTG GAA CTG GCC ATC TG-3’ 




5’-CAA AGA TCC CAT ATT CAA CAC TCA A-3’ 
5’-GGG ATG CCA CCG AGT AGG TA-3’ 
5’-FAM-CTG CAA CAC AAA CAA CAG AAT TTA TTG TCA GTG 
ACA-TAMRA-3’ 




5’-AGA ACC CGG ACC TGC ACA-3’  (Sybr Green qRT-PCR) 
5’-CAG CTC CTT CCA CGC TTT G-3’  
COUP-TFII Hs00819630_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 




5’-TCT GCA CTG CAG GTA TTG ACA A-3’ (Sybr Green qRT-
PCR) 
5’-CTG ATC GAT TCG CAA CGG A-3’ 
VE-CADHERIN  Hs00174344_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 
ENDOGLIN   Hs00164438_m1  (Premade Taqman Gene expression assays, Applied 
Biosystems) 




5’-TGG CAC CAC ACC TTC TAC AAT G-3’ (Sybr Green qRT-
PCR) 
5’-TAG CAA CGT ACA TGG CTG GG-3’ 
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